Moramide intermediate
Clinical data | |
---|---|
Routes of administration | N/A |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
Synonyms | moramide intermediate |
CAS Number | |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C21H25NO3 |
Molar mass | 339.4281 g/mol |
3D model (JSmol) | |
| |
|
Moramide intermediate (3-methyl-4-morpholin-4-yl-2,2-diphenylbutanoic acid, on INCB Yellow List as 2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid) is a moramide precursor scheduled by UN Single Convention on Narcotic Drugs.
In the United States, moramide intermediate is designated as a Schedule II controlled substance,[1] and has an ACSCN of 9802. The 2014 annual manufacturing quota was nil.[2]
See also
- Moramide
- Methadone intermediate
- Pethidine intermediate A
- Pethidine intermediate B (norpethidine)
- Pethidine intermediate C (pethidinic acid)
References
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.